KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baxter International (BAX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Baxter International (BAX) over the last 17 years, with Q4 2025 value amounting to $2.0 billion.

  • Baxter International's Cash & Equivalents rose 1145.12% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year increase of 1145.12%. This contributed to the annual value of $2.0 billion for FY2025, which is 1145.12% up from last year.
  • Per Baxter International's latest filing, its Cash & Equivalents stood at $2.0 billion for Q4 2025, which was up 1145.12% from $1.7 billion recorded in Q3 2025.
  • Baxter International's 5-year Cash & Equivalents high stood at $5.7 billion for Q3 2023, and its period low was $1.4 billion during Q3 2024.
  • For the 5-year period, Baxter International's Cash & Equivalents averaged around $2.4 billion, with its median value being $1.9 billion (2022).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 25702.69% in 2023, then plummeted by 7515.75% in 2024.
  • Over the past 5 years, Baxter International's Cash & Equivalents (Quarter) stood at $3.0 billion in 2021, then crashed by 45.07% to $1.6 billion in 2022, then soared by 89.88% to $3.1 billion in 2023, then plummeted by 42.69% to $1.8 billion in 2024, then rose by 11.45% to $2.0 billion in 2025.
  • Its Cash & Equivalents stands at $2.0 billion for Q4 2025, versus $1.7 billion for Q3 2025 and $1.7 billion for Q2 2025.